1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Deals

Sweden's Trimb Grows European Offering With BioClin Acquisition

 
• By Tom Gallen

Trimb has snapped up Netherlands-based BioClin and gained a portfolio of consumer health brands based on a patented ingredient for the treatment and prevention of microbial complaints.

Businessmen
Trimb secures acquisition of BioClin • Source: Shutterstock

Sweden’s Trimb Healthcare has expanded its consumer health portfolio by acquiring for an undisclosed sum Netherlands-based BioClin and its range of “all-natural brands” to treat microbial imbalance. It is Trimb’s second deal in as many months, following its acquisition of a portfolio of skin-care products from CSS Healthcare Nordic in November.

Describing BioClin as a “leading intimate health company”, Stockholm-based Trimb said it had gained a portfolio of “well known brands”,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

Haleon Takes Full Control Of China JV

 
• By Tom Gallen

Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."

Navamedic Adds OTC Naloxone With DNE Pharma Acquisition

 
• By Tom Gallen

Norway's Navamedic will move into the addiction treatment market with the acquisition of DNE Pharma, adding to its portfolio an OTC opioid overdose reversal spray.

AESGP Annual Meeting: Consumer Health Sector Still Safe Bet For Investors

 
• By David Ridley

A healthy diversity of different types of players and plenty of space for scaling up are among the reasons that investors remain interested in the consumer health sector, according to investment bankers speaking at the recent AESGP Annual Meeting.

Germany’s PharmaSGP To Be Taken Private

 
• By Tom Gallen

Consumer health player PharmaSGP will be taken private by its biggest shareholder, FUTRUE.

More from Business

Haleon Takes Full Control Of China JV

 
• By Tom Gallen

Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."

Perrigo Combines Americas, International Leads Into Global Post In Latest Move To Boost Results

 
• By Malcolm Spicer

Roberto Khoury, Perrigo’s international lead for a year, moves to CCO while his counterpart for the Americas region appointed in September 2023, Catherine "Triona" Schmelter, is leaving with her post eliminated in the firm’s changes.

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By David Ridley

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.